Christopher Gibson - 10 Nov 2023 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Chief Executive Officer, Director
Signature
/s/ Jonathan Golightly, attorney-in-fact
Issuer symbol
RXRX
Transactions as of
10 Nov 2023
Net transactions value
-$121,435
Form type
4
Filing time
17 Nov 2023, 17:50:50 UTC
Previous filing
03 Nov 2023
Next filing
08 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Conversion of derivative security $0 +10,000 +1.2% $0.000000 846,820 10 Nov 2023 Direct F1, F2
transaction RXRX Class A Common Stock Gift $0 -10,000 -1.2% $0.000000 836,820 10 Nov 2023 Direct F1
transaction RXRX Class A Common Stock Tax liability $121,435 -16,913 -2% $7.18 819,907 15 Nov 2023 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RXRX Class B Common Stock Conversion of derivative security $0 -10,000 -0.15% $0.000000 6,501,496 10 Nov 2023 Class A Common Stock 10,000 $0.000000 Direct F1, F2, F7
holding RXRX Stock Option (Right to Buy) 813,600 10 Nov 2023 Class A Common Stock 0 $8.55 Direct F4
holding RXRX Stock Option (Right to Buy) 5,436 10 Nov 2023 Class A Common Stock 0 $11.40 Direct
holding RXRX Stock Option (Right to Buy) 407,676 10 Nov 2023 Class A Common Stock 0 $11.40 Direct F5
holding RXRX Stock Option (Right to Buy) 437,500 10 Nov 2023 Class A Common Stock 0 $2.48 Direct F6
holding RXRX Class B Common Stock 519,000 10 Nov 2023 Class A Common Stock 4,000 $0.000000 by LAHWRAN-3 LLC F7, F8
holding RXRX Class B Common Stock 428,000 10 Nov 2023 Class A Common Stock 20,000 $0.000000 by LAHWRAN-4 LLC F7, F9
holding RXRX Class B Common Stock 119,875 10 Nov 2023 Class A Common Stock 1,000 $0.000000 by Gibson Family Trust F7, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 22, 2022
F2 Represents the automatic conversion of Class B Common Stock into Class A Common Stock in connection with a bona-fide gift of shares by the Reporting Person
F3 Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units.
F4 The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F5 The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F6 The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
F7 Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
F8 The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.
F9 The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.
F10 The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.